Volume 22, numbers 1-47 and 17 1/2; January 3, 1975; January 10, 1975; January 17, 1975; January 24, 1975; January 31, 1975; February 7, 1975; February 14, 1975; February 21, 1975; February 28, 1975; March 7, 1975; March 14, 1975; March 21, 1975;...
These are minutes of an Ad Hoc Committee established by Dr. William Anlyan, Dean of the Duke University Medical School, to review and make recommendations for the Physician's Assistant Program being developed at the Medical Center. The Committee...
Volume 21, numbers 1-47; January 4, 1974; January 11, 1974; January 19, 1974; January 25, 1974; February 1, 1974; February 8, 1974; February 15, 1974; February 22, 1974; March 1, 1974; March 8, 1974; March 15, 1974; March 22, 1974; March 29, 1974;...
Volume 25, numbers 1-50; January 6, 1978; January 13, 1978; January 20, 1978; January 27, 1978; February 3, 1978; February 10, 1978; February 17, 1978; February 24, 1978; March 3, 1978; March 10, 1978; March 17, 1978; March 24, 1978; March 31,...
Volume 18, numbers 1-48; January 8, 1971; January 15, 1971; January 22, 1971; January 29, 1971; February 5, 1971; February 12, 1971; February 19, 1971; March 5, 1971 (Special Issue); March 12, 1971; March 19, 1971; March 26, 1971; April 2, 1971;...
Volume 19, numbers 1-49; January 7, 1972; January 14, 1972; January 21, 1972; February 4, 1972; February 11, 1972; February 18, 1972; February 25, 1972; March 3, 1972; March 10, 1972; March 17, 1972; March 24, 1972; March 31, 1972; April 7, 1972;...
Volume 17, numbers 1-17 and 19-22; January 1970; February 1970; March 1970; April 1970; May 1970; June 1970; July 1970; August 1970; August 1970 (2); September 18, 1970; September 25, 1970; October 2, 1970; October 9, 1970; October 16, 1970;...
USS Squalus (SS-192), a diesel-electric submarine built at the Portsmouth Navy Yard, Portsmouth, New Hampshire and commissioned there on 1 March 1939, suffered a catastrophic valve failure during a test dive off the Isle of Shoals at 0740 on 23...
Background: Metastatic breast cancer (MBC) is incurable, despite recent therapeutic advances resulting in extended trajectories of disease, especially in estrogen receptor positive (ER+) and human epidermal growth factor-2 negative (HER2-) MBC....